In addition, our data further showed that DDX11 mRNA expression was able to distinguish the clinical outcomes in several TCGA cancers, such as adrenocortical carcinoma (ACC) and acute myeloid leukemia (LAML) (Figure 2E). Here, DDX11 is linked to acute myeloid leukemia.